Adomiparin Sodium; Alfa 87-120; Alfa 87-163; Alfa 87-198; Alfa 87-81; Alfa 88-247; Ardeparin Sodium; Badyket; Bemiparin Sodium; Clivarin 1750; Dalteparin Sodium; Deligoparin Sodium; Depo-Heparin; Fragmin; Fragmin IV; H 2149; Hed-Heparin; Hepaflush; Hepagumin; Hepalean; Heparin Fragment Kabi 2165; Heparin sodium; Heparine Choay; Hepathrom; Heprinar; Hepsal; Inno-Hep; Ivor; Kabi 2165; LHN 1; Lioton 1000; Lipo-Hepin; Lipo-Hepinette; Liquaemin Sodium; Liquemin; Logiparin; Longheparin; M 118 Sodium; Minihep; Minolteparin Sodium; Monoparin; Nadroparine Sodium; Normiflo; OP 2000; Panheprin; Parnaparin Sodium; Pularin; RO 11; RO 14; RP 54563; Reviparin Sodium; Semuloparin Sodium; Sevuparin Sodium; Sodium Acid Heparin; Sodium Heparin; Sodium Heparinate; Sodium Parnaparin; Thrombo-Hepin; Thromboliqu
Nadroparin Sodium (Heparin Sodium) is a fully characterized chemical compound used as a reference standard of API Heparin. The standard offered is compliant with regulatory guidelines. Nadroparin Sodium (Heparin Sodium) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 9041-08-1
